Preview Mode Links will not work in preview mode

Outbreak News Interviews

Dec 30, 2018

The biotech company, Valneva announced this month about the promising work and progress on two vaccine candidates--the mosquito borne virus, chikungunya and Lyme disease.

On today's show I am joined by Valneva President and CEO, Thomas Lingelbach to discuss the latest on these vaccine candidates.

Dec 30, 2018

On the final show of the year, I do my annual year in review with a look at the top 10 most important infectious disease news stories of the year, in my opinion of course.

In addition, I unveil the top podcast of 2018 from Outbreak News Interviews (as far as downloads) and the top post of the year.

Thanks for making it...

Dec 22, 2018

According to the World Health Organization (WHO), Neglected tropical diseases (NTDs)– a diverse group of communicable diseases that prevail in tropical and subtropical conditions in 149 countries – affect more than one billion people and cost developing economies billions of dollars every year.

Populations living in...

Dec 22, 2018

The Federal Tick-borne Disease Working Group recently released their first report to Congress about one year after the panel first convened.

The Infectious Diseases Society of America (IDSA) responded to the report in a letter that contained some criticisms of the report.

What is the Federal Tick-borne Disease Working...

Dec 19, 2018

Lyme disease is the most common vector borne-disease in the United States with approximately 300,000 cases reported annually.

It is caused by the spirochetal organism Borrelia burgdorferi.

While the majority of the Lyme disease patients can be cured with 2–4 weeks antibiotic treatment, about 10–20% of...